Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Mills

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|January 13, 2000
A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndromeK D Bardhan, G Bodemar, H Geldof, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1989
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtimeL Halvorsen, F I Lee, I C Wesdorp, et al.
Gastroenterology|March 1, 1980
Gastric secretory studies in humans with impromidine (SK&F 92676)--a specific histamine H2 receptor agonistR H Hunt, J G Mills, J Beresford, et al.
Alimentary Pharmacology & Therapeutics|November 26, 1999
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patientsR H Jones, G Holtmann, L Rodrigo, et al.
Scandinavian Journal of Gastroenterology|January 1, 1980
Histamine H2 receptors and intrinsic factor secretionP C Sharpe, J G Mills, M A Horton, et al.
Digestion|January 1, 1984
A double-blind randomized, controlled study to investigate the efficacy of cimetidine given in addition to conventional therapy in the prevention of stress ulceration and haemorrhage in patients with acute spinal injuryG A Zäch, K E Gyr, E von Alvensleben, et al.
Gut|February 1, 1982
Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonistJ G Mills, P L Brunet, R Griffiths, et al.
British Journal of Clinical Pharmacology|December 1, 1975
Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy manW L Burland, W A Duncan, T Hesselbo, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 1, 1997
Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bidJ H Hegarty, L Halvorsen, B P Hazenberg, et al.
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|May 1, 1987
Continuous 24 hour ambulatory monitoring of intragastric pH in manB K Kapur, P J Howlett, N G Kenyon, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|January 13, 2000
A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndromeK D Bardhan, G Bodemar, H Geldof, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1989
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtimeL Halvorsen, F I Lee, I C Wesdorp, et al.
Gastroenterology|March 1, 1980
Gastric secretory studies in humans with impromidine (SK&F 92676)--a specific histamine H2 receptor agonistR H Hunt, J G Mills, J Beresford, et al.
Alimentary Pharmacology & Therapeutics|November 26, 1999
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patientsR H Jones, G Holtmann, L Rodrigo, et al.
Scandinavian Journal of Gastroenterology|January 1, 1980
Histamine H2 receptors and intrinsic factor secretionP C Sharpe, J G Mills, M A Horton, et al.
Digestion|January 1, 1984
A double-blind randomized, controlled study to investigate the efficacy of cimetidine given in addition to conventional therapy in the prevention of stress ulceration and haemorrhage in patients with acute spinal injuryG A Zäch, K E Gyr, E von Alvensleben, et al.
Gut|February 1, 1982
Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonistJ G Mills, P L Brunet, R Griffiths, et al.
British Journal of Clinical Pharmacology|December 1, 1975
Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy manW L Burland, W A Duncan, T Hesselbo, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 1, 1997
Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bidJ H Hegarty, L Halvorsen, B P Hazenberg, et al.
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|May 1, 1987
Continuous 24 hour ambulatory monitoring of intragastric pH in manB K Kapur, P J Howlett, N G Kenyon, et al.
Pageof 5